BIO-B Bio-Rad Laboratories Inc

USD 279.91 0.00 0
Icon

Bio-Rad Laboratories Inc (BIO-B) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 279.91

0.00 (0.00)%

USD 8.01B

14.00

N/A

N/A

Icon

BIO-B

Bio-Rad Laboratories Inc (USD)
COMMON STOCK | NYE
USD 279.91
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 8.01B

N/A

USD 279.91

Bio-Rad Laboratories Inc (BIO-B) Stock Forecast

N/A

Based on the Bio-Rad Laboratories Inc stock forecast from 0 analysts, the average analyst target price for Bio-Rad Laboratories Inc is not available over the next 12 months. Bio-Rad Laboratories Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bio-Rad Laboratories Inc is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Bio-Rad Laboratories Inc’s stock price was USD 279.91. Bio-Rad Laboratories Inc’s stock price has changed by -17.32% over the past week, -15.74% over the past month and -39.69% over the last year.

No recent analyst target price found for Bio-Rad Laboratories Inc
No recent average analyst rating found for Bio-Rad Laboratories Inc

Company Overview Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufacture...Read More

https://www.bio-rad.com

1000 Alfred Nobel Drive, Hercules, CA, United States, 94547

8,030

December

USD

USA

Adjusted Closing Price for Bio-Rad Laboratories Inc (BIO-B)

Loading...

Unadjusted Closing Price for Bio-Rad Laboratories Inc (BIO-B)

Loading...

Share Trading Volume for Bio-Rad Laboratories Inc Shares

Loading...

Compare Performance of Bio-Rad Laboratories Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIO-B

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bio-Rad Laboratories Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABT
Abbott Laboratories +2.01 (+1.91%) USD182.66B 32.79 18.75

ETFs Containing BIO-B

Symbol Name BIO-B's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bio-Rad Laboratories Inc (BIO-B) Stock

Stock Target Advisor's fundamental analysis for Bio-Rad Laboratories Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on BIO-B's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIO-B's stock to indicate what its average analyst target is.

BIO-B stock's Price/Earning ratio is 3.59. Our analysis grades BIO-B stock's Price / Earning ratio at A+. This means that BIO-B stock's Price/Earning ratio is above 0% of the stocks in the Medical Devices sector in the NYE exchange. Based on this BIO-B may be undervalued for its sector.

The last closing price of BIO-B's stock was USD 279.91.

The most recent market capitalization for BIO-B is USD 8.01B.

Unfortunately we do not have enough analyst data on BIO-B's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bio-Rad Laboratories Inc's stock.

As per our most recent records Bio-Rad Laboratories Inc has 8,030 Employees.

Bio-Rad Laboratories Inc's registered address is 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547. You can get more information about it from Bio-Rad Laboratories Inc's website at https://www.bio-rad.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...